Implantica AG engages in the provision of effective care for serious health conditions and improving patient quality of life by bringing advanced technology into the body. Its product RefluxStop, is a passive CE-marked implant for prevention of gastroesophageal reflux. The company was founded by Peter Forsell in 2015 and is headquartered in Vaduz, Liechtenstein.
Die Digitalisierung ist im Gesundheitswesen angekommen. Nicht umsonst ist der Bereich Electronic Health (eHealth) inzwischen der am schnellsten wachsende Behandlungsbereich der Welt.
The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to be held on Wednesday, June 10, 2026,...
Today, May 15, 2025, the annual general meeting (the “AGM”) of Implantica AG (publ) was held in Ruggell, Liechtenstein. The general meeting resolved to adopt all of the...
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces that on 23 December 2024 the company executed a directed...
